Ginkgo Bioworks CEO Jason Kelly joins Inside the ICE House to explain how Ginkgo is building the infrastructure to make biology programmable at scale — automating the lab work that has long bottlenecked scientific progress and offering experimentation as a cloud-based service to pharma, agriculture, and academic researchers. Kelly also details how a landmark collaboration with OpenAI demonstrated that AI can now autonomously design and iterate on biological experiments, pointing toward a future where the $120 billion spent annually on manual research gets dramatically more productive.